Crossroads Health Ventures
Venture capitalActively deployingPre-Seed–Series A · 6 people tracked
Investment thesis
Crossroads Health Ventures invests in early-stage life sciences innovation within the United States, focusing on companies developing novel technologies and approaches in healthcare and biotech sectors. The firm emphasizes alignment with its strategic limited partners and provides mentorship and introductions through a network of 100+ corporate partners.
Source: firm website, verified Jul 21, 2026.
Team · 6 people
from the firm's websiteTing Gootee, CFA and CAIA charterholder, serves as EVP of Digital Adoption at CICP and as Managing Director of Crossroads Health Ventures, overseeing digital transformation and strategic investments.
Vince Wong, JD and MBA holder, serves as Managing Director of Crossroads Health Ventures, leading investment strategy and company guidance.
Samantha Ginther, who holds a Master of Public Health degree, serves as a Principal at Crossroads Health Ventures focusing on investment and company development.
Chelsea Linder serves as VP of Innovation & Entrepreneurship at TechPoint, contributing to startup support and innovation strategy initiatives.
Christy Wright, President and CEO of AgriNovus Indiana, contributes strategic oversight and industry connections to the Crossroads Health Ventures network.
Emily Atkinson, PhD, serves as Senior Director of Innovation at BioCrossroads, contributing expertise to the innovation and strategy initiatives of the organization.
Board seats · per SEC filings · 2
what is this? ⓘ$700K raise · filed Apr 2026 · via Samantha W.P. Ginther
$3M raise · filed May 2021 · via Ting Gootee
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Crossroads Health Ventures invest at?
- Crossroads Health Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Crossroads Health Ventures focus on?
- Crossroads Health Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
An early-stage venture capital firm investing in technology founders building solutions across multiple sectors.